Organon (NYSE: OGN) reported Q4 EPS of $0.90, $0.01 worse than the analyst estimate of $0.91. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.59 billion.

GUIDANCE:

Organon sees FY2025 revenue of $6.12-6.32 billion, versus the consensus of $6.43 billion.

For earnings history and earnings-related data on Organon (OGN) click here.